Navigation Links
Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone
Date:1/10/2011

tics in general, and the TOMM40 biomarker specifically, to identify at-risk individuals who may be candidates for treatment in a pharmacogenetics-assisted clinical trial," said Dr. Roses. "We look forward to working with a partner like Takeda, who shares our commitment to reducing the prevalence of Alzheimer's disease over the next 20-30 years."

Alzheimer's disease is a degenerative brain disease characterized by a progressive decline in memory, thinking, comprehension, calculation, language, learning capacity and judgment sufficient to impair personal activities of daily living. Approximately 18 million people worldwide are currently suffering from Alzheimer's disease, and the rate of occurrence doubles every five years for those between 65 and 85 years of age.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.

About Zinfandel Pharmaceuticals

Zinfandel Pharmaceuticals, based in Durham, NC, is a privately held company dedicated to using pharmacogenetics to improve prediction of risk for Alzheimer's disease and thus facilitate the development of effective therapies.


'/>"/>
SOURCE Takeda Pharmaceutical Company Limited; Zinfandel Pharmaceutcals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
2. FDA Continues Review of Takedas New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes
3. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
4. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
7. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
8. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
9. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
10. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
11. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... DES MOINES, Iowa (PRWEB) July 23, 2014 ... will join the business as vice president of Agricultural ... from Mendel Biotechnology where he served most recently as ... brings extensive biotechnology and business leadership in the seed ... DuPont Pioneer,” said Paul E. Schickler , president ...
(Date:7/23/2014)... Sciences, Inc. (OTCQB: GBLX), a medical cannabis research and development ... marijuana dispensary locations in Las Vegas, Nevada ... Clark County, Nevada dispensary for which the company ... GrowBLOX Sciences, CEO Craig Ellins stated, "We ... in the City of Las Vegas . ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
(Date:7/22/2014)... Web) July 21, 2014 (PRWEB) July 23, 2014 ... Biomaterials, at Rutgers University. , The goal ... ideas across the full spectrum of scientists working ... research and development topics that represent the most ... been programmed to:,     Provide faculty ...
Breaking Biology Technology:DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 2GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 3OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2
... 2011 Celtaxsys, Inc., a private biopharmaceutical company defining new ... veteran, H. Daniel Perez, M.D., to its Board of Directors ... has joined the Celtaxsys team," says Dr. Michael R. Hanley, ... more than 25 years of high level pharmaceutical executive experience ...
... 5, 2011 Northwest Biotherapeutics (OTC.BB: NWBO) today announced ... financing arrangements, including a $3 million investment already received, ... funding on fixed, specified and favorable terms, at such ...  This series of financing arrangements will provide a strong ...
... 2011 Recent biopharmaceutical product launches have produced both ... area. Faced with a continually evolving launch landscape, organizations ... in the current launch environment. In ... success factors and failure points facing new product launches, ...
Cached Biology Technology:Dr. H. Daniel Perez Joins Celtaxsys Board of Directors 2Northwest Biotherapeutics Announces Series of Financing Arrangements 2Northwest Biotherapeutics Announces Series of Financing Arrangements 3Northwest Biotherapeutics Announces Series of Financing Arrangements 4Creating a Road Map for Successful Cardiovascular New Product Launch 2
(Date:7/23/2014)... Cell Foundation (NYSCF) and Beyond Batten Disease Foundation (BBDF) ... and explore new treatments and ultimately find a cure ... , NYSCF scientists will create induced pluripotent stem (iPS) ... by juvenile Batten disease as well as unaffected family ... back the clock" on skin cells to a time ...
(Date:7/23/2014)... by ischemic preconditioning has been confirmed by many ... a study released in the Neural Regeneration ... Yong Liu and co-workers from Tongji Hospital Affiliated ... and Technology, China performed cerebral ischemic preconditioning in ... explored the mechanism underlying the neuroprotective effect of ...
(Date:7/23/2014)... are working to restore New Hampshire and Maine,s only ... has found that in the last decade, cottontail populations ... seen a 50 percent contraction of their range. ... at risk of becoming extinct in the region, according ... of New Hampshire College of Life Sciences and Agriculture ...
Breaking Biology News(10 mins):NYSCF partners with Beyond Batten Disease Foundation to fight juvenile Batten disease 2NYSCF partners with Beyond Batten Disease Foundation to fight juvenile Batten disease 3UNH NHAES researchers work to save endangered New England cottontail 2UNH NHAES researchers work to save endangered New England cottontail 3
... Tests on the influence that a stress-related hormone has ... on understanding how it influences human learning, according to ... Professor in Comparative Human Development, has found that when ... quickly if they have a modest amount of cortisol, ...
... been lifted at the request of the PIO. , Without ... sideways, even though they lack flippers or fins. University of ... pelvic, abdominal and rib muscles to shift their lungs like ... the head when they surface and sideways when they roll. ...
... the Genome Sequencing Center (GSC) at Washington University in St. ... of the corn genome. In the fall of ... Agriculture (USDA) and the Department of Energy (DOE), awarded $32 ... goal of the project led by the Washington University GSC ...
Cached Biology News:Research with squirrels provides clues on hormone's role in human learning 2How alligators rock and roll 2How alligators rock and roll 3How alligators rock and roll 4How alligators rock and roll 5All eyes and ears on the corn genome 2All eyes and ears on the corn genome 3
... sufficient materials for 1,464 array sample elements. , , ... , Blocker BSA in PBS (10X): 50 ml , ... Saline: 8 packs , 10% Tween-20: 2 x 10 ... x 25 ml , SuperSignal West Pico Stable Peroxide: ...
... Mouse polyclonal antibody raised against ... Immunogen: XAGE2 ... a.a) partial recombinant protein with ... Accession Number: NM_130777 ...
... proteins are used to immunize rabbits. , Agro-Bio ... quantity of antigen and quality of the antibodies ... per protocol in order to avoid animal variability. ... is approximately 75 mL per rabbit.,150 to 250 ...
...
Biology Products: